Andros Pharmaceuticals Co., Ltd. (6917)
Market Closed
16 Oct, 05:30 AM
TWSE TWSE Primary NT$
33. 05
+0.05
+0.1515%
NT$
718.59M Market Cap
- P/E Ratio
- Div Yield
699,544 Volume
- Eps
NT$ 33
Previous Close Want to track 6917 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Andros Pharmaceuticals Co., Ltd. (6917) Statistics
Valuation metrics
Market Cap 718.59M
Enterprise value 1.87B
Trailing P/E (ttm) -54.6
Forward P/E -
PEG ratio -0.55
Price/Sales (ttm) 166.44
Price/Book (mrq) 3.88
Enterprise Value/Revenue 164.78
Enterprise Value/EBITDA -29.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 342.05K
Average volume (90 days) 353.62K
Price summary
52-Week low 18.35
52-Week high 45.95
Beta -
50-Day moving average 34.31
200-Day moving average 32.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 53:50
Last split Date 18 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.95%
Operating margin -6.25%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.21
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.09
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 12.91%
Book value per share (mrq) 8.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
